Outcomes of Renal Transplantation in Brunei Darussalam over a Twenty-Year Period (1993–2012)

Table 4

Commercialised graft and patient survivals.

Authors	Year	Country	Journal	Number	Country of transplant	Graft outcome	Patient outcome
Tan [1]	2013	Brunei		20	China, India, Indonesia, Philippines	5- and 10-year graft survival at 90% and 70.3%	5- and 10-year patient survival at 94.5% and 83.5%
Vathsala [9]	2010	Singapore	Clin Transpl	192	China, India	5- and 10-year graft survivals for DD transplants from China	NA
Morad and Lim [10]	2000	Malaysia	Transplant Proc	389	Not discussed	5-year survival at 72%	5-year survival at 82%
MDTR [5]	2012	Malaysia	MDTR		Not discussed	5-year graft survival at 87%	NA
Quinibi [11]	1997	Saudi Arabia	Clin Transpl	540	India	5-year survival at 72%	5-year survival at 92%
Ghods and Savaj [12]	2006	Iran	Clin J Am Soc Nephrol	1499	Iran	Graft 5- and 10-year survival at 74.4% and 48.8%, respectively	Patient 5- and 10-year survival at 87.1% and 72.2%
Ghods [13]	2002	Iran	Nephrol Dial Transplant	942	Iran	5- and 10-year survival at 64.2% and 43.7%, respectively	5- and 10-year survival at 83.7% and 73.3%, respectively
Kwon et al. [14]	2011	Republic of Korea	J Korean Med Sci	462	China	Survival of 96.5% (median follow-up 21.2 months)	Survival of 96.8% (median follow-up 21.2 months)
Sever et al. [15]	2001	Turkey	Kidney Int	115	India, Iraq, Iran	2-, 5-, and 7-year survival at 84%, 66%, and 53%, respectively	2-, 5-, and 7-year survival at 90%, 80%, and 74%, respectively
Çolakolu et al. [16]	1998	Turkey	Nephron	127	India	5-year survival at 57%	5-year survival at 92%
Rizvi et al. [17]	2009	Pakistan	Transpl Int	126	Pakistan	Graft 1- and 5-year survival at 86% and 45%, respectively	NA